
|Articles|November 20, 2015
Drug Spending and Access Limitations Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/drug-spending-and-access-limitations-highlight-spe" target="_blank">View the story "Drug Spending and Access Limitations Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
2
CMS Announces 15 Drugs for Third Cycle of Medicare Drug Price Negotiation Program
3
New 2025 Hypertension Management Guidelines Include Key Updates
4
Dextromethorphan Emerges as a Novel Antidepressant Pathway for Treatment-Resistant Depression
5


















